Kerr W. Holbrook - 04 Mar 2022 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role
SVP, GM Chronic Care
Signature
/s/ Mojirade James, as attorney-in-fact for Kerr W. Holbrook
Issuer symbol
AVNS
Transactions as of
04 Mar 2022
Net transactions value
$0
Form type
4
Filing time
08 Mar 2022, 10:32:32 UTC
Previous filing
10 May 2021
Next filing
11 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Award $0 +12,949 +63% $0.000000 33,463 04 Mar 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents time-based restricted share units awarded pursuant to the Issuer's 2021 Long Term Incentive Plan. The award will vest 1/3 on March 4, 2023, 1/3 on March 4, 2024 and 1/3 on March 4, 2025.
F2 Total beneficially owned includes 213 shares acquired on June 30, 2021 and 392 shares acquired on December 31, 2021 under the Issuer's Employee Stock Purchase Plan.